M.v.i. and Erythema multiforme - a phase IV clinical study of FDA data

Summary:

Erythema multiforme is reported as a side effect among people who take M.v.i. (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e), especially for people who are male, 60+ old, also take Prevacid, and have Cellulitis.

The phase IV clinical study analyzes which people have Erythema multiforme when taking M.v.i.. It is created by eHealthMe based on reports of 2,495 people who have side effects when taking M.v.i. from the FDA, and is updated regularly.

What is M.v.i.?

M.v.i. has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. eHealthMe is studying from 2,498 M.v.i. users. Check the latest studies of M.v.i..

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,702 drugs and 2,921 conditions by eHealthMe. Check the latest studies of Erythema multiforme.

On Jul, 30, 2026

2,495 people reported to have side effects when taking M.v.i..
Among them, 11 people (0.44%) have Erythema multiforme.

Among these 11 people:

What is the gender of people who have Erythema multiforme when taking M.v.i.? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Erythema multiforme when taking M.v.i.? *

What are other drugs people take besides M.v.i.? *

What are other side effects people have besides Erythema multiforme? *

Fever: 6 people, 54.55%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 3 people, 27.27%
Rash Erythematous (redness of the skin): 3 people, 27.27%
Itching: 2 people, 18.18%
Chills (felling of cold): 2 people, 18.18%
Rash Pruritic (redness with itching): 2 people, 18.18%
Sloughing Of Skin (coming off in a layer or section of skin): 2 people, 18.18%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 1 person, 9.09%
Drug Maladministration: 1 person, 9.09%
Epidermal Necrolysis (skin condition that is usually caused by a reaction to drugs): 1 person, 9.09%

What are the existing conditions these people have? *

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 9.09%
Cellulitis (infection under the skin): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take M.v.i. and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to M.v.i.:

M.v.i. (2,498 reports)

Erythema multiforme treatments and more:

Erythema multiforme (56,072 reports)

How severe was Erythema multiforme and when was it recovered:

Erythema multiforme in M.v.i.

Expand to all the drugs that have ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e:

Erythema multiforme and drugs with ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (539 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of M.v.i.:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of M.v.i.) and M.v.i. (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.